Even More Evidence for the Value of Early HPV Vaccination
Even More Evidence for the Value of Early HPV Vaccination An exciting new study in Scotland found no cases of invasive cervical cancer in young women who had gotten the
Nearly half of males in the United States have genital human papillomavirus (HPV), according to a study published in JAMA Oncology.
HPV is the most common sexually transmitted infection, and experts believe most sexually active individuals have an HPV infection at some point. CDC estimates there are 79 million total cases of HPV in the U.S. (with 14 million new cases each year).
Of the HPV types associated with sexual transmission, some are linked with genital warts while others are associated with cancers of the cervix, vagina, vulva, penis, and anus (along with a number of head and neck cancers). Most cases of HPV are harmless, however, and are cleared naturally by the immune system in a year or two.
The study by Jasmine Han, MD, and her colleagues was done with nearly 1,900 men ages 18-59 as part of the National Health and Nutrition Examination Survey (NHANES) 2013-2014. NHANES is a series of continuing studies assessing the health of adults and children in the U.S. Overall, HPV was detected in 45% of males in the study (25% of subjects were found to have a high-risk type). Unlike HPV infections in females which decline after peaking in mid-20s (click here for data on females), the results from this study found high rates of HPV in males across all age groups.
The researchers also found only 11% of the study subjects eligible for HPV vaccination had received the shots. HPV vaccines are approved for males and females ages 9-26 and are nearly 100% effective in blocking infections and diseases related to the HPV types covered, and the authors write “Our study indicates that male HPV vaccination may have a greater effect on HPV infection transmission and cancer prevention in men and women than previously estimated.”
Reference: Han JJ, et al. Prevalence of Genital Human Papillomavirus Infection and Human Papillomavirus Vaccination Rates Among US Adult Men. JAMA Oncol, published online January 19, 2017.
Even More Evidence for the Value of Early HPV Vaccination An exciting new study in Scotland found no cases of invasive cervical cancer in young women who had gotten the
Cervical Health Awareness Month in January is a time to learn about cervical health and cancer prevention. The World Health Organization has a plan for the elimination of cervical cancer through vaccination and screening—we can get there!
Vaccinations are a great way to protect yourself, empower yourself, and to keep you — and your sex life — healthy and happy. Help us spread awareness about available vaccinations!
Is one shot enough? A new study adds to evidence that one dose of the HPV vaccine might be enough to provide protection against cervical cancer.
A new study revealed a disturbing trend in health knowledge; fewer people seem to understand the connection between HPV and certain types of cancer including cervical, oral, anal, and penile cancers.
HPV (a.k.a. human papillomavirus) is the name of a group of viruses that infect the skin. In women, HPV can lead to cervical cancer (and other types of cancer as well), but what about in men? Think you know about HPV and men? Take the quiz and find out.
ASHA believes that all people have the right to the information and services that will help them to have optimum sexual health. We envision a time when stigma is no longer associated with sexual health and our nation is united in its belief that sexuality is a normal, healthy, and positive aspect of human life.
ABOUT
GET INVOLVED
ASHA WEBSITES
GET HELP
© 2024 American Sexual Health Association